$41.7 million boost to commercialise lifesaving medical discoveries

Portfolio, Industry, Science and Technology, Releases

An innovative nasal treatment to fight COVID-19, common colds and flu is being taken to the next stage of testing, thanks to the Morrison Government’s $500 million Biomedical Translation Fund. Developed by Australian biotech company Ena Respiratory, INNA-051 works by stimulating the innate immune system, the first line of defence against the invasion of pathogens…

CSIRO UPGRADING WORLD CLASS FACILITY TO FIGHT DISEASES LIKE CORONAVIRUS

Portfolio, Industry, Science and Technology, Releases

CSIRO’s work to better understand the virus that leads to COVID-19 and test potential vaccines is being given a substantial boost with a $220 million upgrade of its high containment biosecurity research facility in Geelong. The facility, formerly known as the Australian Animal Health Laboratory (AAHL), has also been renamed the Australian Centre for Disease…